BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35071337)

  • 1. Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Front Cardiovasc Med; 2021; 8():695822. PubMed ID: 35071337
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis.
    Hu MJ; Tan JS; Jiang WY; Gao XJ; Yang YJ
    Ther Adv Chronic Dis; 2022; 13():20406223221078088. PubMed ID: 35295615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
    Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR
    JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate Versus Staged Multivessel PCI Strategies in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Systematic Review and Meta-Analysis.
    Hu MJ; Yang YJ; Yang JG
    Am J Med Sci; 2022 Feb; 363(2):161-173. PubMed ID: 34274323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Am J Cardiol; 2019 Aug; 124(3):334-342. PubMed ID: 31174834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.
    Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA
    JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis.
    Guo WQ; Li L; Su Q; Sun YH; Wang XT; Dai WR; Li HQ
    Clin Epidemiol; 2018; 10():1037-1051. PubMed ID: 30197541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials.
    Feng Y; Li S; Hu S; Wan J; Shao H
    Front Cardiovasc Med; 2022; 9():1000664. PubMed ID: 36225962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and multivessel disease patients undergoing primary percutaneous coronary intervention: A meta-analysis and trial sequential analysis.
    Wang CH; Zhang SY; Jin XF
    Int J Cardiol; 2017 Feb; 228():844-852. PubMed ID: 27907885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis.
    Tarantini G; D'Amico G; Brener SJ; Tellaroli P; Basile M; Schiavo A; Mojoli M; Fraccaro C; Marchese A; Musumeci G; Stone GW
    JACC Cardiovasc Interv; 2016 Sep; 9(17):1765-76. PubMed ID: 27609250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials.
    Xu H; Zhang X; Li J; Liu H; Hu X; Yang J
    BMC Cardiovasc Disord; 2019 Apr; 19(1):91. PubMed ID: 31010423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J
    Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Levett JY; Windle SB; Filion KB; Cabaussel J; Eisenberg MJ
    Am J Cardiol; 2020 Nov; 135():40-49. PubMed ID: 32871112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials.
    Bajraktari G; Bytyçi I; Henein MY; Alfonso F; Ahmed A; Jashari H; Bhatt DL
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100549. PubMed ID: 32577495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Song YJ; Shin HC; Yang JI; Lee HY; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Jang JS
    J Interv Cardiol; 2015 Feb; 28(1):1-13. PubMed ID: 25689544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.